400 related articles for article (PubMed ID: 8651291)
1. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
[TBL] [Abstract][Full Text] [Related]
2. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
[TBL] [Abstract][Full Text] [Related]
4. Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.
Manga P; Kromberg JG; Box NF; Sturm RA; Jenkins T; Ramsay M
Am J Hum Genet; 1997 Nov; 61(5):1095-101. PubMed ID: 9345097
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities.
Zhao H; Boissy RE
Am J Med Sci; 1994 Dec; 308(6):322-30. PubMed ID: 7985719
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
7. Mutant alleles at the brown locus encoding tyrosinase-related protein-1 (TRP-1) affect proliferation of mouse melanocytes in culture.
Sarangarajan R; Zhao Y; Babcock G; Cornelius J; Lamoreux ML; Boissy RE
Pigment Cell Res; 2000 Oct; 13(5):337-44. PubMed ID: 11041210
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
[TBL] [Abstract][Full Text] [Related]
9. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
[TBL] [Abstract][Full Text] [Related]
10. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
[TBL] [Abstract][Full Text] [Related]
11. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of oculocutaneous albinism.
Oetting WS; King RA
J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
[TBL] [Abstract][Full Text] [Related]
13. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
Oetting WS; Mentink MM; Summers CG; Lewis RA; White JG; King RA
Am J Hum Genet; 1991 Jul; 49(1):199-206. PubMed ID: 1905879
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
15. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
[TBL] [Abstract][Full Text] [Related]
16. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.
Durham-Pierre D; Gardner JM; Nakatsu Y; King RA; Francke U; Ching A; Aquaron R; del Marmol V; Brilliant MH
Nat Genet; 1994 Jun; 7(2):176-9. PubMed ID: 7920637
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
18. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
19. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
20. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
